Efficacy and safety of omalizumab therapy in urticaria vasculitis

Efficacy and safety of omalizumab therapy in urticaria vasculitis

Urticarial vasculitis (UV) is a small-vessel leukocytoclastic vasculitis characterized by different clinical manifestations ranging from long-lasting urticarial lesions to severe and potentially life-threatening multi-organ involvement. Omalizumab (OMA), anti-IgE recombinant humanized IgG1 monoclona...

Full description

Bibliographic Details
Main Authors: Fiorella Petrelli, Daiana Giannini, Silvia Bilia, Isabella Del Corso, Valeria Rocchi, Paola Migliorini, Ilaria Puxeddu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Allergy
Subjects:
urticarial vasculitis
omalizumab
anti IgE
therapy
biological agent
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2022.952079/full

Internet

https://www.frontiersin.org/articles/10.3389/falgy.2022.952079/full

Similar Items